Cargando…
Nucleic acid amplification tests reduce delayed diagnosis and misdiagnosis of pulmonary tuberculosis
The clinical impact of nucleic acid amplification (NAA) tests on reducing delayed diagnosis and misdiagnosis of pulmonary TB (PTB) has rarely been investigated. PTB patients were classified into a frontline NAA group, an add-on NAA group, and a no NAA group. The outcomes of interest were the proport...
Autores principales: | Feng, Jia-Yih, Lin, Chou-Jui, Wang, Jann-Yuan, Chien, Shun-Tien, Lin, Chih-Bin, Huang, Wei-Chang, Lee, Chih-Hsin, Shu, Chin-Chung, Yu, Ming-Chih, Lee, Jen-Jyh, Chiang, Chen-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283405/ https://www.ncbi.nlm.nih.gov/pubmed/35835940 http://dx.doi.org/10.1038/s41598-022-16319-8 |
Ejemplares similares
-
Performance of Nucleic Acid Amplification Tests in Patients with Presumptive Pulmonary Tuberculosis in Taiwan
por: Huang, Wei-Chang, et al.
Publicado: (2022) -
Treatment Outcomes of Multidrug-Resistant Tuberculosis in Taiwan: Tackling Loss to Follow-up
por: Yu, Ming-Chih, et al.
Publicado: (2018) -
Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort study
por: Lee, Chih-Hsin, et al.
Publicado: (2017) -
The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis
por: Chiang, Chen Yuan, et al.
Publicado: (2015) -
Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease
por: Lee, Chih-Hsin, et al.
Publicado: (2012)